Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review

BACKGROUND: Patients with advanced pancreatic cancer have a poor prognosis and high burden of cancer-related symptoms. It is necessary to assess the trade-off of clinical benefits and possible harms of treatments with anticancer drugs (TAD). This systematic review aims to compare the effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar, Josefina, Bracchiglione, Javier, Savall-Esteve, Olga, Antequera, Alba, Bottaro-Parra, David, Gutiérrez-Valencia, Marta, Martínez-Peralta, Susana, Pericay, Carles, Tibau, Ariadna, Bonfill, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422698/
https://www.ncbi.nlm.nih.gov/pubmed/37573294
http://dx.doi.org/10.1186/s12885-023-11207-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422698/
https://www.ncbi.nlm.nih.gov/pubmed/37573294
http://dx.doi.org/10.1186/s12885-023-11207-4

Ejemplares similares